BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22807549)

  • 21. Factors That Influence Confirmation of Neisseria gonorrhoeae Positivity by Molecular Methods.
    Cuschieri K; Shepherd J; Graham C; Guerendiain D; Templeton KE
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of CDC-recommended approaches for confirmatory testing of positive Neisseria gonorrhoeae nucleic acid amplification test results.
    Moncada J; Donegan E; Schachter J
    J Clin Microbiol; 2008 May; 46(5):1614-9. PubMed ID: 18322062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the BD Viper System with XTR Technology to the Gen-Probe APTIMA COMBO 2 Assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens.
    Mushanski LM; Brandt K; Coffin N; Levett PN; Horsman GB; Rank EL
    Sex Transm Dis; 2012 Jul; 39(7):514-7. PubMed ID: 22706212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.
    Black CM; Driebe EM; Howard LA; Fajman NN; Sawyer MK; Girardet RG; Sautter RL; Greenwald E; Beck-Sague CM; Unger ER; Igietseme JU; Hammerschlag MR
    Pediatr Infect Dis J; 2009 Jul; 28(7):608-13. PubMed ID: 19451856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.
    Chernesky MA; Martin DH; Hook EW; Willis D; Jordan J; Wang S; Lane JR; Fuller D; Schachter J
    J Clin Microbiol; 2005 Jan; 43(1):127-31. PubMed ID: 15634960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonorrhoea notifications and nucleic acid amplification testing in a very low-prevalence Australian female population.
    Chow EP; Fehler G; Read TR; Tabrizi SN; Hocking JS; Denham I; Bradshaw CS; Chen MY; Fairley CK
    Med J Aust; 2015 Apr; 202(6):321-3. PubMed ID: 25832159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of APTIMA Combo 2 assay to the diagnosis of gonorrhoea in genitourinary medicine setting.
    Moss S; Mallinson H
    Int J STD AIDS; 2007 Aug; 18(8):551-4. PubMed ID: 17686218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-screening for Neisseria gonorrhoeae and Chlamydia trachomatis in the human immunodeficiency virus clinic--high yields and high acceptability.
    Soni S; White JA
    Sex Transm Dis; 2011 Dec; 38(12):1107-9. PubMed ID: 22082720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in gonorrhoea positivity by nucleic acid amplification test versus culture among Australian heterosexual men with a low prevalence of gonorrhoea, 2007-2014.
    Mannion PK; Fairley CK; Fehler G; Tabrizi SN; Tan WS; Chen MY; Bradshaw CS; Chow EP
    Sex Transm Infect; 2016 Dec; 92(8):625-628. PubMed ID: 26888660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can culture confirmation of gonococcal infection be improved in female subjects found to be positive by nucleic acid amplification tests in community clinics?
    Gopal Rao G; Bacon L; Evans J; Dejahang Y; Hardwick R; Michalczyk P; Wong J; Donaldson A
    Sex Transm Infect; 2009 Dec; 85(7):531-3. PubMed ID: 19703846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of 2005 Public Health Laboratory Network Neisseria gonorrhoeae nucleic acid amplification tests guidelines.
    Whiley DM; Lahra MM;
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E42-5. PubMed ID: 26063097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect on Neisseria gonorrhoeae screening rates in an integrated clinic following the introduction of dual nucleic acid amplification tests.
    Pease E; Desmond N; Ashby J
    Int J STD AIDS; 2013 Mar; 24(3):251. PubMed ID: 24400351
    [No Abstract]   [Full Text] [Related]  

  • 33. Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.
    Van Der Pol B; Ferrero DV; Buck-Barrington L; Hook E; Lenderman C; Quinn T; Gaydos CA; Lovchik J; Schachter J; Moncada J; Hall G; Tuohy MJ; Jones RB
    J Clin Microbiol; 2001 Mar; 39(3):1008-16. PubMed ID: 11230419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it time to move to nucleic acid amplification tests screening for pharyngeal and rectal gonorrhoea in men who have sex with men to improve gonorrhoea control?
    Fairley CK; Chen MY; Bradshaw CS; Tabrizi SN
    Sex Health; 2011 Mar; 8(1):9-11. PubMed ID: 21371376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleic acid amplification tests for the diagnosis of Neisseria gonorrhoeae in low-prevalence settings: a review of the evidence.
    Fifer H; Ison CA
    Sex Transm Infect; 2014 Dec; 90(8):577-9. PubMed ID: 25013081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort Study.
    Wind CM; Schim van der Loeff MF; Unemo M; Schuurman R; van Dam AP; de Vries HJC
    Clin Infect Dis; 2016 Jun; 62(11):1348-1355. PubMed ID: 26962074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men.
    McNally LP; Templeton DJ; Jin F; Grulich AE; Donovan B; Whiley DM; Cunningham PH
    Clin Infect Dis; 2008 Jul; 47(2):e25-7. PubMed ID: 18549310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections.
    Bachmann LH; Johnson RE; Cheng H; Markowitz LE; Papp JR; Hook EW
    J Clin Microbiol; 2009 Apr; 47(4):902-7. PubMed ID: 19193848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An audit of the results of the Roche Amplicor gonorrhoea test on female genital samples--a cheaper and more sensitive method than culture in an urban English population.
    Hardwick C; White D; Osman H
    Int J STD AIDS; 2007 May; 18(5):347-8. PubMed ID: 17524199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays.
    Brook G
    Sex Transm Infect; 2015 Dec; 91(8):539-44. PubMed ID: 25935930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.